Global Metabotropic Glutamate Receptor 7 Market By Product Type (JBPOS-0101, PGT-117) And By End-Users/Application (Generalized Anxiety Disorder, Infantile Spasm) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

  • AMR-984666
  • April 2021
  • Pharmaceuticals
  • 113 Pages

Report Preview

The Metabotropic Glutamate Receptor 7 Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)

The Metabotropic Glutamate Receptor 7 Market has been valued at US$ xx Mn in the year 2020 and is anticipated to attain US$ xx Mn by the year 2028 along with a CAGR of xx%

Metabotropic Glutamate Receptor 7 Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Metabotropic Glutamate Receptor 7 market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2019
Forecast Period Covered 2019 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Product Type JBPOS-0101, PGT-117, ADX-71743, Others
Applications Generalized Anxiety Disorder, Infantile Spasm, Status Epilepticus, Others
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Addex Therapeutics Ltd, Aevi Genomic Medicine Inc, Bio-Pharm Solutions Co Ltd, Pragma Therapeutics SAS
 
Metabotropic Glutamate Receptor 7 Market Competitive and Premeditated Analysis
In the Metabotropic Glutamate Receptor 7 report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Metabotropic Glutamate Receptor 7 research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Metabotropic Glutamate Receptor 7 Market Segmentation Analysis:
The Metabotropic Glutamate Receptor 7 market is segmented into various sections such as product types, applications as well as end users and regions. Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

Segmentation based on type includes JBPOS-0101, PGT-117, ADX-71743, Others   

The application segment includes   Generalized Anxiety Disorder, Infantile Spasm, Status Epilepticus, Others

Major Key Players for Global Metabotropic Glutamate Receptor 7 Market:
The Metabotropic Glutamate Receptor 7 market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Addex Therapeutics Ltd, Aevi Genomic Medicine Inc, Bio-Pharm Solutions Co Ltd, Pragma Therapeutics SAS
 
The Metabotropic Glutamate Receptor 7 market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Regional Analysis of the Metabotropic Glutamate Receptor 7 market:
The Metabotropic Glutamate Receptor 7 market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

The Global segmentation of the Metabotropic Glutamate Receptor 7 market:
By Type:
  • JBPOS-0101
  • PGT-117
  • ADX-71743
  • Others

By Application
  • Generalized Anxiety Disorder
  • Infantile Spasm
  • Status Epilepticus
  • Others

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


 
Major Factors Included and highlighted in the Metabotropic Glutamate Receptor 7 report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Metabotropic Glutamate Receptor 7 market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Metabotropic Glutamate Receptor 7 market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Metabotropic Glutamate Receptor 7 market is included in the report.
 
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Metabotropic Glutamate Receptor 7 market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Metabotropic Glutamate Receptor 7 market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Metabotropic Glutamate Receptor 7 market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Metabotropic Glutamate Receptor 7 market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Metabotropic Glutamate Receptor 7 market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Metabotropic Glutamate Receptor 7 Market Snapshot
          2.1.1. Global Metabotropic Glutamate Receptor 7 Market By Type,2019
               2.1.1.1.JBPOS-0101
               2.1.1.2.PGT-117
               2.1.1.3.ADX-71743
               2.1.1.4.Others
          2.1.2. Global Metabotropic Glutamate Receptor 7 Market By Application,2019
               2.1.2.1.Generalized Anxiety Disorder
               2.1.2.2.Infantile Spasm
               2.1.2.3.Status Epilepticus
               2.1.2.4.Others
          2.1.3. Global Metabotropic Glutamate Receptor 7 Market By End-use,2019
          2.1.4. Global Metabotropic Glutamate Receptor 7 Market By Geography,2019

3. Global Metabotropic Glutamate Receptor 7 Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Metabotropic Glutamate Receptor 7 Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Metabotropic Glutamate Receptor 7 Market Size (US$), By Type, 2018 – 2028

5. Global Metabotropic Glutamate Receptor 7 Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Metabotropic Glutamate Receptor 7 Market Size (US$), By Application, 2018 – 2028

6. Global Metabotropic Glutamate Receptor 7 Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Metabotropic Glutamate Receptor 7 Market Size (US$), By End-use, 2018 – 2028

7. Global Metabotropic Glutamate Receptor 7 Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Metabotropic Glutamate Receptor 7 Market Analysis, 2018 – 2028 
          7.2.1. North America Metabotropic Glutamate Receptor 7 Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Metabotropic Glutamate Receptor 7 Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Metabotropic Glutamate Receptor 7 Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Metabotropic Glutamate Receptor 7 Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Metabotropic Glutamate Receptor 7 Market Analysis, 2018 – 2028 
          7.3.1.  Europe Metabotropic Glutamate Receptor 7 Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Metabotropic Glutamate Receptor 7 Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Metabotropic Glutamate Receptor 7 Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Metabotropic Glutamate Receptor 7 Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Metabotropic Glutamate Receptor 7 Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Metabotropic Glutamate Receptor 7 Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Metabotropic Glutamate Receptor 7 Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Metabotropic Glutamate Receptor 7 Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Metabotropic Glutamate Receptor 7 Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Metabotropic Glutamate Receptor 7 Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Metabotropic Glutamate Receptor 7 Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Metabotropic Glutamate Receptor 7 Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Metabotropic Glutamate Receptor 7 Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Metabotropic Glutamate Receptor 7 Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Metabotropic Glutamate Receptor 7 Market Analysis, 2018 – 2028 
          7.6.1.  MEA Metabotropic Glutamate Receptor 7 Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Metabotropic Glutamate Receptor 7 Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Metabotropic Glutamate Receptor 7 Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Metabotropic Glutamate Receptor 7 Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Metabotropic Glutamate Receptor 7 Providers
        8.4.1 Addex Therapeutics Ltd
                8.1.1 Business Description
                8.1.2 Addex Therapeutics Ltd Geographic Operations
                8.1.3 Addex Therapeutics Ltd Financial Information
                8.1.4 Addex Therapeutics Ltd Product Positions/Portfolio
                8.1.5 Addex Therapeutics Ltd Key Developments
        8.4.2 Aevi Genomic Medicine Inc
                8.2.1 Business Description
                8.2.2 Aevi Genomic Medicine Inc Geographic Operations
                8.2.3 Aevi Genomic Medicine Inc Financial Information
                8.2.4 Aevi Genomic Medicine Inc Product Positions/Portfolio
                8.2.5 Aevi Genomic Medicine Inc Key Developments
        8.4.3 Bio-Pharm Solutions Co Ltd
                8.3.1 Business Description
                8.3.2 Bio-Pharm Solutions Co Ltd Geographic Operations
                8.3.3 Bio-Pharm Solutions Co Ltd Financial Information
                8.3.4 Bio-Pharm Solutions Co Ltd Product Positions/Portfolio
                8.3.5 Bio-Pharm Solutions Co Ltd Key Developments
        8.4.4 Pragma Therapeutics SAS
                8.4.1 Business Description
                8.4.2 Pragma Therapeutics SAS Geographic Operations
                8.4.3 Pragma Therapeutics SAS Financial Information
                8.4.4 Pragma Therapeutics SAS Product Positions/Portfolio
                8.4.5 Pragma Therapeutics SAS Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Metabotropic Glutamate Receptor 7 Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Metabotropic Glutamate Receptor 7 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Metabotropic Glutamate Receptor 7 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Metabotropic Glutamate Receptor 7 Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Metabotropic Glutamate Receptor 7 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Metabotropic Glutamate Receptor 7 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Metabotropic Glutamate Receptor 7 Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Metabotropic Glutamate Receptor 7 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Metabotropic Glutamate Receptor 7 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Metabotropic Glutamate Receptor 7 Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Metabotropic Glutamate Receptor 7 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Metabotropic Glutamate Receptor 7 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Metabotropic Glutamate Receptor 7 Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Metabotropic Glutamate Receptor 7 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Metabotropic Glutamate Receptor 7 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Metabotropic Glutamate Receptor 7 Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Metabotropic Glutamate Receptor 7: Market Segmentation 
FIG. 2 Global Metabotropic Glutamate Receptor 7 Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Metabotropic Glutamate Receptor 7 Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Metabotropic Glutamate Receptor 7 Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Metabotropic Glutamate Receptor 7 Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Metabotropic Glutamate Receptor 7 Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Metabotropic Glutamate Receptor 7 Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Metabotropic Glutamate Receptor 7 Providers, 2019
FIG. 11 Global Metabotropic Glutamate Receptor 7 Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Metabotropic Glutamate Receptor 7 Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Metabotropic Glutamate Receptor 7 Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Metabotropic Glutamate Receptor 7 Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Metabotropic Glutamate Receptor 7 Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Metabotropic Glutamate Receptor 7 Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Metabotropic Glutamate Receptor 7 Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Metabotropic Glutamate Receptor 7 Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Metabotropic Glutamate Receptor 7 market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Metabotropic Glutamate Receptor 7 Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Metabotropic Glutamate Receptor 7 Market Value, By Segment1, 2018 – 2028
TABLE  North America Metabotropic Glutamate Receptor 7 Market Value, By Segment2, 2018 – 2028
TABLE  North America Metabotropic Glutamate Receptor 7 Market Value, By Country, 2018 – 2028
TABLE  Europe Metabotropic Glutamate Receptor 7 Market Value, By Segment1, 2018 – 2028
TABLE  Europe Metabotropic Glutamate Receptor 7 Market Value, By Segment2, 2018 – 2028
TABLE  Europe Metabotropic Glutamate Receptor 7 Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Metabotropic Glutamate Receptor 7 Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Metabotropic Glutamate Receptor 7 Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Metabotropic Glutamate Receptor 7 Market Value, By Country, 2018 – 2028
TABLE  Latin America Metabotropic Glutamate Receptor 7 Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Metabotropic Glutamate Receptor 7 Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Metabotropic Glutamate Receptor 7 Market Value, By Country, 2018 – 2028
TABLE  MEA Metabotropic Glutamate Receptor 7 Market Value, By Segment1, 2018 – 2028
TABLE  MEA Metabotropic Glutamate Receptor 7 Market Value, By Segment2, 2018 – 2028
TABLE  MEA Metabotropic Glutamate Receptor 7 Market Value, By Country, 2018 – 2028
TABLE  Addex Therapeutics Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Aevi Genomic Medicine Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bio-Pharm Solutions Co Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pragma Therapeutics SAS: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Metabotropic Glutamate Receptor 7 Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Metabotropic Glutamate Receptor 7 Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Metabotropic Glutamate Receptor 7 Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Metabotropic Glutamate Receptor 7 Market, By Geography, 2019 (US$ Mn)
FIG.  Global Metabotropic Glutamate Receptor 7 Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Metabotropic Glutamate Receptor 7 Providers, 2016
FIG.  Global Metabotropic Glutamate Receptor 7 Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global JBPOS-0101 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global PGT-117 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global ADX-71743 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Metabotropic Glutamate Receptor 7 Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Generalized Anxiety Disorder Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Infantile Spasm Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Status Epilepticus Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Metabotropic Glutamate Receptor 7 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Metabotropic Glutamate Receptor 7 Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Metabotropic Glutamate Receptor 7 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Metabotropic Glutamate Receptor 7 Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Metabotropic Glutamate Receptor 7 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Metabotropic Glutamate Receptor 7 Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Metabotropic Glutamate Receptor 7 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Metabotropic Glutamate Receptor 7 Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Metabotropic Glutamate Receptor 7 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Metabotropic Glutamate Receptor 7 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Metabotropic Glutamate Receptor 7 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Metabotropic Glutamate Receptor 7 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Metabotropic Glutamate Receptor 7 Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Metabotropic Glutamate Receptor 7 Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Metabotropic Glutamate Receptor 7 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Metabotropic Glutamate Receptor 7 Market Value, 2018 – 2028, (US$ Mn)